Roy­al­ty Phar­ma inks MS deal with Im­muNext; X4 sells its pri­or­i­ty re­view vouch­er

Plus, news about Paci­ra Bio­sciences, Cas­sa­va Sci­ences, Mer­ck, Monopar Ther­a­peu­tics, Eli Lil­ly and Opti­nose:

Roy­al­ty Phar­ma signs MS deal: The com­pa­ny will

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER